Greenberg Financial Group’s Atossa Therapeutics ATOS Stock Holding History

Greenberg Financial Group’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$10.7K	Buy	+1,214	New	+$15.4K	﹤0.01%	112

Other funds holding ATOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Greenberg Financial Group's ATOS Position: Q4 2025 in Review

Greenberg Financial Group opened a new position in Atossa Therapeutics (ATOS) in Q4 2025: 1,214 shares worth $10.7K. The stake represents ﹤0.01% of the portfolio and ranks #112 among its holdings.

67 funds tracked by Wall St. Rank hold ATOS as of Q4 2025.

Greenberg Financial Group held 1,214 shares of Atossa Therapeutics worth $10.7K as of Q4 2025.
Atossa Therapeutics was a new Greenberg Financial Group position in Q4 2025.
Atossa Therapeutics made up ﹤0.01% of Greenberg Financial Group's portfolio in Q4 2025, its #112 holding.
67 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2025.

Based on Greenberg Financial Group's 13F filing for Q4 2025, filed 22 Jan 2026.